KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Amortization of Deferred Charges (2016 - 2021)

Jazz Pharmaceuticals has reported Amortization of Deferred Charges over the past 11 years, most recently at $15.7 million for Q1 2021.

  • For Q1 2021, Amortization of Deferred Charges rose 30.73% year-over-year to $15.7 million; the TTM value through Mar 2021 reached $60.3 million, up 27.68%, while the annual FY2020 figure was $56.7 million, 22.12% up from the prior year.
  • Amortization of Deferred Charges for Q1 2021 was $15.7 million at Jazz Pharmaceuticals, down from $16.0 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $16.0 million in Q4 2020 and troughed at $5.6 million in Q1 2017.
  • A 5-year average of $11.3 million and a median of $11.3 million in 2018 define the central range for Amortization of Deferred Charges.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 89.08% in 2018 and fell as far as 4.62% in 2018.
  • Year by year, Amortization of Deferred Charges stood at $10.8 million in 2017, then increased by 4.62% to $11.3 million in 2018, then grew by 6.11% to $12.0 million in 2019, then surged by 33.93% to $16.0 million in 2020, then fell by 2.23% to $15.7 million in 2021.
  • Business Quant data shows Amortization of Deferred Charges for JAZZ at $15.7 million in Q1 2021, $16.0 million in Q4 2020, and $15.8 million in Q3 2020.